必威体育betway888, April 1, 2024 - The 必威体育betway888 Academy of Higher Education (MAHE), a premier institution of higher learning and research, and Kore Additive Manufacturing and Medical Reconstruction Pvt. Ltd. (KOREAMMR), a leading startup in 3D bioprinting and biomedical research, are thrilled to announce their newly formed partnership. This strategic alliance, formalised through a memorandum of understanding signed on March 30, 2024, aims to accelerate advancements in the development of three-dimensional scaffolds for tissue regeneration.

The collaborative research efforts will be conducted at the state-of-the-art 必威体育betway888 Centre for Biotherapeutics 必威体育betway888 (MCBR) and KOREAMMR facilities. This partnership seeks to leverage and augment the existing capabilities of both organisations, promising significant breakthroughs in the biomedical field. "Through this collaboration, we are setting a new precedent for the integration of academic research and industry innovation. The combined expertise and resources of MAHE and KOREAMMR will undoubtedly propel us toward remarkable achievements in biomedical research and product development," said Dr. P Giridhar Kini, MAHE Registrar.

KOREAMMR, renowned for its pioneering work in developing 3D Bioprinted products, organ on chip systems, and research in stem cell-based tissue grafts, views this partnership as a critical step towards streamlining product development. "Our collaboration with MAHE is a game-changer, significantly reducing the time to market for our innovative solutions," remarked Mr. Chaitanya Doshi, CEO of KOREAMMR.

The GMP-compliant facilities at MCBR are designated as the initial manufacturing sites for new product development, with potential pilot clinical studies to be conducted at Kasturba Medical College, 必威体育betway888. "This collaboration not only brings together leading minds in the field of biotechnology but also sets the stage for future medical breakthroughs that could transform patient care. We are especially excited about the possibilities this partnership opens up for creating real-world applications that address critical health challenges," said Professor and Coordinator of MCBR, Dr. Raviraja NS.

Facilitated by Prof. (Dr.) Harish Kumar, Director of Corporate Relations at MAHE, the partnership will primarily involve collaboration with Dr. S. V. Kirthanashri, Associate Professor at MCBR, and Dr. S. Varadharajan, Coordinator Intellectual Property & Technology Transfer Office at MAHE, who will lead the efforts towards technology transfer and commercialisation.

MAHE and KOREAMMR are committed to harnessing the power of 3D bioprinting and biomaterials research to pave the way for innovative medical treatments and technologies, reflecting their shared vision for improving healthcare outcomes worldwide.